Hans-Peter Gerber - Sep 18, 2024 Form 4 Insider Report for SUTRO BIOPHARMA, INC. (STRO)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Edward C. Albini as attorney-in-fact for Hans-Peter Gerber
Stock symbol
STRO
Transactions as of
Sep 18, 2024
Transactions value $
-$52,851
Form type
4
Date filed
9/20/2024, 04:09 PM
Previous filing
Mar 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STRO Common Stock Options Exercise $0 +37.5K $0.00 37.5K Sep 18, 2024 Direct
transaction STRO Common Stock Tax liability -$52.9K -13.4K -35.68% $3.95 24.1K Sep 18, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STRO Restricted Stock Units (RSUs) Options Exercise $0 -37.5K -25% $0.00 113K Sep 18, 2024 Common Stock 37.5K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
F2 Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
F3 The RSU award vests annually as to 1/4th of the total award beginning on September 18, 2024, subject to the reporting person's continued service to the Issuer on each vesting date.